Düren, Germany

Sven Kühnert

USPTO Granted Patents = 21 

 

Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 2011-2017

Loading Chart...
Loading Chart...
21 patents (USPTO):Explore Patents

Title: Sven Kühnert: Innovator in Medicinal Chemistry from Düren, DE

Introduction

Sven Kühnert, based in Düren, Germany, is a prominent inventor with a remarkable portfolio of 21 patents. His innovative contributions predominantly lie in the field of medicinal chemistry, where he focuses on the treatment of various diseases and disorders.

Latest Patents

Among Sven Kühnert's latest patents are significant advancements in the treatment and prophylaxis of diseases mediated by the Translocator Protein (TSPO). One of these inventions relates to certain compounds that aim to tackle TSPO mediated diseases and disorders. Additionally, he has developed specific carboxamides functioning as KCNQ2/3 modulators. This invention encompasses not only the compounds but also the processes for their preparation, as well as the medicaments that utilize them.

Career Highlights

Sven has worked at Gruenenthal GmbH, a company known for its dedication to innovative medical solutions. His experience there has helped to refine his expertise in medicinal development and drug discovery. His commitment to advancing healthcare solutions is reflected in his extensive patent filings.

Collaborations

Throughout his career, Sven Kühnert has collaborated with notable peers, including Gregor Bahrenberg and Wolfgang Schröder. These collaborations highlight the importance of teamwork and shared expertise in fostering innovation and achieving breakthroughs in medicinal chemistry.

Conclusion

Sven Kühnert stands out as a key figure in the realm of medicinal innovations, especially with his proven track record of patents that contribute significantly to modern medicine. His ongoing work promises to play a vital role in addressing complex health issues linked to TSPO and KCNQ2/3 pathways. As he continues to innovate, the medical community eagerly anticipates the potential impact of his inventions on patient care and treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…